Frequencies of HIV-reactive B cells in seropositive and seronegative individuals
- 1 January 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 87 (1) , 31-36
- https://doi.org/10.1111/j.1365-2249.1992.tb06409.x
Abstract
SUMMARY: Peripheral blood mononuclear cells (PBMC) from HIV-infected seropositive (HIV+) but not from normal, seronegative (HIV-) individuals are known to produce anti-HIV antibodies in vitro, in the absence or presence of pokeweed mitogen (PWM). Previous studies showed that up to 20–40% of spontaneously immunoglobulin-secreting B cells from HIV+ individuals are HIV-specific. To analyse the frequency of anti-HIV B cells among “total” peripheral blood B cells in the present study, we used a limiting dilution assay in which EL-4 thymoma cells induce clones of immunoglobulln-secreting cells in activated as well as resting B cells. Anti-HIV B cells were detected not only in 11/12 HIV+ individuals (with frequencies from 1/910 lo 1/21 500 B cells cultured; one negative test was from a person undergoing seroconversion), but also in 4/9 HIV normal blood donors (1/16200 to 1/49000 B cells cultured) and in 3/6 newborns from HIV mothers (1/11 800 to l/26 600 B cells cultured). The mean frequency was nine times higher in the HIV individuals than in the normal donors. As in previous studies, only the cells from HIV individuals generated anti-HIV antibodies in PBMC bulk cultures with or without PWM. The relative proportion of specific anti-HIV antibody total immunoglobulin in PBMC bulk cultures was 800 times higher by the mean than in EL-4 B cell cultures from HIV individuals (whereby the total immunoglobulin secretion for equal numbers of B cells cultured was 500 times lower for PBMC). These different results obtained with different assays suggest that in seropositives most anti-HIV B cells belong to an activated B compartment which is quite small, even in a disease with B cell hyperactivity. Therefore, the specific B cells are strongly diluted among the EL-4 cell-responsive, total B cells. On the other hand, the EL-4 assay can detect HIV-reactive B cells in the B ceil repertoire of normal, non-infected individuals.Keywords
This publication has 19 references indexed in Scilit:
- Transforming growth factor-beta and suppression of humoral immune responses in HIV infection.Journal of Clinical Investigation, 1991
- B-cell activation and HIV-1 infection: Deeds and misdeedsImmunology Today, 1990
- A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.Journal of Clinical Investigation, 1990
- Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells.The Journal of Experimental Medicine, 1990
- Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expressionImmunology Today, 1990
- Cell surface antigen CD5 is a marker for activated human B cellsEuropean Journal of Immunology, 1989
- Theoretical and Practical Aspects of B‐Cell Activation: Murine and Human SystemsImmunological Reviews, 1987
- Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and anti‐malaria responder B cell frequenciesEuropean Journal of Immunology, 1987
- Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.Journal of Clinical Investigation, 1986
- Human B cell differentiation. II. Pokeweed mitogen-responsive B cells belong to a surface immunoglobulin D-negative subpopulation.The Journal of Experimental Medicine, 1982